| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
| AR protein | 5 | 0 | 0 | 5 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
| retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
| estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| IDH1 | 1 | 0 | 0 | 1 |
| Histone H2A.x | 2 | 0 | 0 | 2 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 2 | 2 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
| Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Avidin | 0 | 0 | 1 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 0 | 0 | 1 |
| Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 2 | 2 | 4 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 4 | 2 | 7 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 0 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 2 | 2 | 4 |
| Glutamate receptor 2 | 2 | 0 | 0 | 2 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 1 | 2 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 2 | 2 | 6 |
| Adenosine receptor A2b | 0 | 0 | 1 | 3 |
| Adenosine receptor A2b | 0 | 1 | 1 | 2 |
| Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 4 | 2 | 8 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 0 | 1 | 1 |
| Adenosine kinase | 0 | 0 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
| Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
| Adenosine kinase | 0 | 1 | 0 | 2 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
| 5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
| Adenosine transporter 1 | 0 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 2 | 0 | 0 | 2 |
| RAR-related orphan receptor gamma | 2 | 0 | 0 | 2 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Matrix protein 2 | 0 | 1 | 1 | 2 |
| Matrix protein 2 | 0 | 1 | 2 | 3 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 2 | 0 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
| ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
| Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| Albumin | 0 | 0 | 1 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
| Capsid protein | 0 | 1 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
| Reverse transcriptase/RNaseH | 0 | 0 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 4 | 0 | 4 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
| ATAD5 protein, partial | 1 | 0 | 0 | 1 |
| USP1 protein, partial | 2 | 0 | 0 | 2 |
| TDP1 protein | 4 | 0 | 0 | 4 |
| Smad3 | 1 | 0 | 0 | 1 |
| vasopressin V1b receptor | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| relaxin receptor 2 isoform 1 | 1 | 0 | 0 | 1 |
| Ataxin-2 | 4 | 0 | 0 | 4 |
| NS5 | 0 | 0 | 2 | 2 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
| retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
| estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
| farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
| pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
| peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| geminin | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Polymerase basic protein 2 | 0 | 0 | 1 | 1 |
| RNA-directed RNA polymerase catalytic subunit | 0 | 0 | 1 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
| Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 0 | 1 | 1 |
| GABA theta subunit | 1 | 0 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
| Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
| Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
| Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
| Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
| Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
| Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
| Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
| Luciferase | 1 | 0 | 0 | 1 |
| SMAD family member 2 | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| GLS protein | 1 | 0 | 0 | 1 |
| SMAD family member 3 | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
| progesterone receptor | 1 | 0 | 0 | 1 |
| G | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
| activating transcription factor 6 | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Interferon beta | 1 | 0 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 4 | 0 | 5 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 2 | 1 | 3 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A5 | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Vasopressin V1a receptor | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 0 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 1 | 4 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Plasmepsin V | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 3 |
| Protease | 0 | 2 | 1 | 3 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| Cereblon isoform 4 | 0 | 1 | 0 | 1 |
| RNA-directed RNA polymerase | 0 | 0 | 1 | 2 |
| Protein cereblon | 0 | 1 | 0 | 1 |
| Chain A, MALTOPORIN | 0 | 0 | 1 | 1 |
| Chain B, MALTOPORIN | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 9 | 0 | 1 | 1 | 2 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
| Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
| Transcription factor p65 | 0 | 1 | 0 | 1 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
| NAD(P)H dehydrogenase [quinone] 1 | 0 | 0 | 0 | 1 |
| Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |